Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence.
about
Diabetic nephropathy: the proteinuria hypothesis.Matrix metalloproteinases and diabetic vascular complications.Molecular-specific effects of angiotensin II antagonists: clinical relevance to treating hypertension?The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus.Telmisartan provides better renal protection than valsartan in a rat model of metabolic syndrome.Anterior Diabetic Retinopathy Studied by Ultra-widefield Angiography.Recent changes in the landscape of combination RAS blockade.Angiotensin inhibition and longevity: a question of hydration.An Angiotensin II (Ang II) Type 1 Receptor Blocker, Telmisartan, Improves Insulin Resistance in KK-A(y) Diabetic Mice.The telmisartan renoprotective study from incipient nephropathy to overt nephropathy--rationale, study design, treatment plan and baseline characteristics of the incipient to overt: angiotensin II receptor blocker, telmisartan, Investigation on Type
P2860
Q36061335-A09E2829-B545-4DC7-B2C3-01318C9A08A3Q36081593-DFEDA071-2828-44E9-80B7-7EF568907876Q36223165-BA006377-7BBE-4B4D-ACA2-F63B904E86C5Q36909521-10AFBAF0-7E39-4FA0-AAB2-E2DB6E21E91EQ37041284-1364A2E0-FC3D-4391-98E2-BE855B696B5FQ37325132-07CEEF3C-40FD-436B-981A-512B050A21D1Q37629835-BAAC0978-E2B0-4C40-B650-F545F846E08AQ37821796-56A91F8F-D9A8-413F-91C1-5162C96035FFQ39525498-27A772C5-46A7-461E-A217-0208B82D8338Q46864138-716D557A-34EE-44FE-ACED-F66EB7F83675
P2860
Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Losartan and other angiotensin ...... f the clinical trial evidence.
@ast
Losartan and other angiotensin ...... f the clinical trial evidence.
@en
type
label
Losartan and other angiotensin ...... f the clinical trial evidence.
@ast
Losartan and other angiotensin ...... f the clinical trial evidence.
@en
prefLabel
Losartan and other angiotensin ...... f the clinical trial evidence.
@ast
Losartan and other angiotensin ...... f the clinical trial evidence.
@en
P1476
Losartan and other angiotensin ...... f the clinical trial evidence.
@en
P304
P356
10.1016/S0149-2918(03)90091-9
P577
2003-12-01T00:00:00Z